With the widespread use of antibiotics, drug-resistant bacterial infections have become a significant threat to human health. Finding new antibacterial strategies that can effectively control drug-resistant bacterial infections has become an urgent task. Unlike small molecule drugs that target bacterial proteins, antisense oligonucleotide (ASO) can target genes related to bacterial resistance, pathogenesis, growth, reproduction and biofilm formation. By regulating the expression of these genes, ASO can inhibit or kill bacteria, providing a novel approach for the development of antibacterial drugs. To overcome the challenge of delivering antisense oligonucleotide into bacterial cells, various drug delivery systems have been applied in this field, including cell-penetrating peptides, lipid nanoparticles and inorganic nanoparticles, which have injected new momentum into the development of antisense oligonucleotide in the antibacterial realm. This review summarizes the current development of small nucleic acid drugs, the antibacterial mechanisms, targets, sequences and delivery vectors of antisense oligonucleotide, providing a reference for the research and development of antisense oligonucleotide in the treatment of bacterial infections.

Aim To explore the mechanism and mate-rial basis of Shenkang injection(SKI)in the treatment of renal fibrosis(RF)by bioinformatics and in vitro experiments.Methods The differentially expressed genes of RF were screened by GEO database.With the help of CMAP database,based on the similarity princi-ple of gene expression profile,the drugs that regulated RF were repositioned,and then the components of SKI potential treatment RF were screened by molecular fin-gerprint similarity analysis.At the same time,the core targets and pathways of SKI regulating RF were predic-ted based on network pharmacology.Finally,it was verified by molecular docking and cell experiments.Results Based on the GEO database,two RF-related data sets were screened,and CMAP was relocated to three common RF therapeutic drugs(saracatinib,da-satinib,pp-2).Molecular fingerprint similarity analysis showed that RF therapeutic drugs had high structural similarity with five SKI components such as salvianolic acid B and hydroxysafflor yellow A.Molecular docking results showed that salvianolic acid B,hydroxysafflor yellow A and other components had good binding abili-ty with MMP1 and MMP13,which were the core targets of SKI-regulated potential treatment of RF.Network pharmacology analysis suggested that the core targets of SKI were mainly enriched in signaling pathways such as Relaxin and AGE-RAGE.Cell experiments showed that SKI could significantly reduce the mRNA expres-sion levels of AGER,NFKB1,COL1A1,SERPINE1,VEGFC in AGE-RAGE signaling pathway and MMP1 and MMP13 in Relaxin signaling pathway in RF model cells,and significantly increase the mRNA expression level of RXFP1.Conclusions SKI can play a role in the treatment of RF by regulating Relaxin and AGE-RAGE signaling pathways,and its material basis may be salvianolic acid B,hydroxysafflor yellow A and other components.

Objective:To delineate the clinical characteristics and outcomes associated with severe cardiac toxicity during the preconditioning phase of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with aplastic anemia (AA).Methods:This retrospective case series study included 31 patients with severe AA who underwent allo-HSCT and were diagnosed with severe cardiac toxicity at the Hematology Department of Peking University People′s Hospital from August 2012 to June 2022. The clinical manifestations of severe cardiac toxicity observed during the preconditioning process were assessed. Patient survival was assessed using the Kaplan-Meier method.Results:In this cohort of 31 patients, the median follow-up period was 9 days (range: 4-365 days). Severe cardiac toxicity manifested within 6 days after the initial cyclophosphamide (Cy) administration. Twenty patients died within 30 days of initiating Cy preconditioning, of which 16 patients died due to severe cardiac toxicity within 25 days. Patients whose cardiac function improved within 30 days post-preconditioning showed a median survival duration of 222 days ( n=11). Troponin I (TNI) levels in patients who died within 30 days of initiating Cy preconditioning began increasing on day 5 post-Cy, peaking sharply by day 9 after a notable rise on day 8. B-type natriuretic peptide (BNP) levels in patients who died within 30 days of initiating Cy preconditioning started to rise from day 1, stabilized between days 2 and 5, and then doubled daily from days 6 to 8, remaining elevated thereafter. Notably, the initial increases in BNP and TNI correlated with electrocardiogram (ECG) signs of low voltage and T-wave inversion in 83.87% of cases ( n=26). Most patients ( n=28, 90.32%) were administered corticosteroid therapy. In those with restored cardiac function, the ejection fraction returned to >50% within 30 days of initiating Cy preconditioning. Conclusions:Patients with severe cardiac toxicity during the preconditioning phase of allo-HSCT typically exhibit early, sustained, and marked elevations in myocardial damage markers, including BNP and TNI, accompanied by ECG abnormalities following Cy administration, with BNP often increasing first. These indicators are associated with rapid disease progression and high mortality. Prompt initiation of treatment upon clinical diagnosis is critical for improving survival outcomes.

Patients with severe trauma require an extremely timely treatment and transfusion plays an irreplaceable role in the emergency treatment of such patients. An increasing number of evidence-based medicinal evidences and clinical practices suggest that patients with severe traumatic bleeding benefit from early transfusion of low-titer group O whole blood or hemostatic resuscitation with red blood cells, plasma and platelet of a balanced ratio. However, the current domestic mode of blood supply cannot fully meet the requirements of timely and effective blood transfusion for emergency treatment of patients with severe trauma in clinical practice. In order to solve the key problems in blood supply and blood transfusion strategies for emergency treatment of severe trauma, Branch of Clinical Transfusion Medicine of Chinese Medical Association, Group for Trauma Emergency Care and Multiple Injuries of Trauma Branch of Chinese Medical Association, Young Scholar Group of Disaster Medicine Branch of Chinese Medical Association organized domestic experts of blood transfusion medicine and trauma treatment to jointly formulate Chinese expert consensus on blood support mode and blood transfusion strategies for emergency treatment of severe trauma patients ( version 2024). Based on the evidence-based medical evidence and Delphi method of expert consultation and voting, 10 recommendations were put forward from two aspects of blood support mode and transfusion strategies, aiming to provide a reference for transfusion resuscitation in the emergency treatment of severe trauma and further improve the success rate of treatment of patients with severe trauma.

Aim To investigate the effect of quercetin on the aging model of bone marrow mesenchymal stem cells established under microgravity. Methods Using 3D gyroscope, a aging model of bone marrow mesenchymal stem cells was constructed, and after receiving quercetin and microgravity treatment, the anti-aging effect of the quercetin was evaluated by detecting related proteins and oxidation indexes. Results Compared to the control group, the expressions of age-related proteins p21, pi6, p53 and RB in the microgravity group significantly increased, while the expressions of cyclin D1 and lamin B1 significantly decreased, with statistical significance (P<0.05). In the microgravity group, mitochondrial membrane potential significantly decreased (P<0.05), ROS accumulation significantly increased (P <0.05), SOD content significantly decreased and MDA content significantly increased (P<0.05). Compared to the microgravity group, the expressions of age-related proteins p21, pi6, p53 and RB in the quercetin group significantly decreased, while the expressions of cyclin D1 and lamin B1 significantly increased, with statistical significance (P<0.05). In the quercetin group, mitochondrial membrane potential significantly increased (P<0.05), ROS accumulation significantly decreased (P<0.05), SOD content significantly increased and MDA content significantly decreased (P<0.05). Conclusions Quercetin can resist oxidation, protect mitochondrial function and normal cell cycle, thus delaying the aging of bone marrow mesenchymal stem cells induced by microgravity.

Objective:It analyzes the resource allocation efficiency and its changing trend of 17 types of medical institutions in Beijing from 2016 to 2022,discusses the problems existing in resource allocation,and provides reference suggestions for improving the efficiency of health resource allocation.Methods:The Banker-Chames-Cooper(BCC)model in Data Envelopment Analysis(DEA)was used to statically analyze the health resource allocation efficiency of 17 types of medical institutions in Beijing in 2022.The Malmquist index model was used to dynamically analyze the health resource allocation efficiency of 17 types of medical institutions in Beijing from 2016 to 2022.Results:In 2022,the overall comprehensive efficiency of medical institutions in Beijing was not high,with an average of 0.804.There were 6 types of medical institutions with effective production efficiency(35.30％),4 types of medical institutions with weak production efficiency(23.50％),and 7 types of medical institutions with ineffective production efficiency(41.20％).From 2016 to 2022,the total factor productivity change index of general hospitals,orthopedic hospitals,other specialized hospitals and nursing homes was greater than 1,and the average total factor productivity change index was 0.907.Conclusion:The allocation efficiency of health resources in various medical institutions in Beijing needs to be improved.It is suggested that the government should strengthen macro-control and allocate health resources in combination with the market;accelerate the promotion of hierarchical diagnosis and treatment system,adjust the structure of medical resources,and improve the utilization rate of resources;make full use of psychiatric hospital health resources,avoid resource waste;improve technical ability and promote technological innovation.

Objective:It analyzes the resource allocation efficiency and its changing trend of 17 types of medical institutions in Beijing from 2016 to 2022,discusses the problems existing in resource allocation,and provides reference suggestions for improving the efficiency of health resource allocation.Methods:The Banker-Chames-Cooper(BCC)model in Data Envelopment Analysis(DEA)was used to statically analyze the health resource allocation efficiency of 17 types of medical institutions in Beijing in 2022.The Malmquist index model was used to dynamically analyze the health resource allocation efficiency of 17 types of medical institutions in Beijing from 2016 to 2022.Results:In 2022,the overall comprehensive efficiency of medical institutions in Beijing was not high,with an average of 0.804.There were 6 types of medical institutions with effective production efficiency(35.30％),4 types of medical institutions with weak production efficiency(23.50％),and 7 types of medical institutions with ineffective production efficiency(41.20％).From 2016 to 2022,the total factor productivity change index of general hospitals,orthopedic hospitals,other specialized hospitals and nursing homes was greater than 1,and the average total factor productivity change index was 0.907.Conclusion:The allocation efficiency of health resources in various medical institutions in Beijing needs to be improved.It is suggested that the government should strengthen macro-control and allocate health resources in combination with the market;accelerate the promotion of hierarchical diagnosis and treatment system,adjust the structure of medical resources,and improve the utilization rate of resources;make full use of psychiatric hospital health resources,avoid resource waste;improve technical ability and promote technological innovation.

Objective:It analyzes the resource allocation efficiency and its changing trend of 17 types of medical institutions in Beijing from 2016 to 2022,discusses the problems existing in resource allocation,and provides reference suggestions for improving the efficiency of health resource allocation.Methods:The Banker-Chames-Cooper(BCC)model in Data Envelopment Analysis(DEA)was used to statically analyze the health resource allocation efficiency of 17 types of medical institutions in Beijing in 2022.The Malmquist index model was used to dynamically analyze the health resource allocation efficiency of 17 types of medical institutions in Beijing from 2016 to 2022.Results:In 2022,the overall comprehensive efficiency of medical institutions in Beijing was not high,with an average of 0.804.There were 6 types of medical institutions with effective production efficiency(35.30％),4 types of medical institutions with weak production efficiency(23.50％),and 7 types of medical institutions with ineffective production efficiency(41.20％).From 2016 to 2022,the total factor productivity change index of general hospitals,orthopedic hospitals,other specialized hospitals and nursing homes was greater than 1,and the average total factor productivity change index was 0.907.Conclusion:The allocation efficiency of health resources in various medical institutions in Beijing needs to be improved.It is suggested that the government should strengthen macro-control and allocate health resources in combination with the market;accelerate the promotion of hierarchical diagnosis and treatment system,adjust the structure of medical resources,and improve the utilization rate of resources;make full use of psychiatric hospital health resources,avoid resource waste;improve technical ability and promote technological innovation.

Objective:It analyzes the resource allocation efficiency and its changing trend of 17 types of medical institutions in Beijing from 2016 to 2022,discusses the problems existing in resource allocation,and provides reference suggestions for improving the efficiency of health resource allocation.Methods:The Banker-Chames-Cooper(BCC)model in Data Envelopment Analysis(DEA)was used to statically analyze the health resource allocation efficiency of 17 types of medical institutions in Beijing in 2022.The Malmquist index model was used to dynamically analyze the health resource allocation efficiency of 17 types of medical institutions in Beijing from 2016 to 2022.Results:In 2022,the overall comprehensive efficiency of medical institutions in Beijing was not high,with an average of 0.804.There were 6 types of medical institutions with effective production efficiency(35.30％),4 types of medical institutions with weak production efficiency(23.50％),and 7 types of medical institutions with ineffective production efficiency(41.20％).From 2016 to 2022,the total factor productivity change index of general hospitals,orthopedic hospitals,other specialized hospitals and nursing homes was greater than 1,and the average total factor productivity change index was 0.907.Conclusion:The allocation efficiency of health resources in various medical institutions in Beijing needs to be improved.It is suggested that the government should strengthen macro-control and allocate health resources in combination with the market;accelerate the promotion of hierarchical diagnosis and treatment system,adjust the structure of medical resources,and improve the utilization rate of resources;make full use of psychiatric hospital health resources,avoid resource waste;improve technical ability and promote technological innovation.

Objective:It analyzes the resource allocation efficiency and its changing trend of 17 types of medical institutions in Beijing from 2016 to 2022,discusses the problems existing in resource allocation,and provides reference suggestions for improving the efficiency of health resource allocation.Methods:The Banker-Chames-Cooper(BCC)model in Data Envelopment Analysis(DEA)was used to statically analyze the health resource allocation efficiency of 17 types of medical institutions in Beijing in 2022.The Malmquist index model was used to dynamically analyze the health resource allocation efficiency of 17 types of medical institutions in Beijing from 2016 to 2022.Results:In 2022,the overall comprehensive efficiency of medical institutions in Beijing was not high,with an average of 0.804.There were 6 types of medical institutions with effective production efficiency(35.30％),4 types of medical institutions with weak production efficiency(23.50％),and 7 types of medical institutions with ineffective production efficiency(41.20％).From 2016 to 2022,the total factor productivity change index of general hospitals,orthopedic hospitals,other specialized hospitals and nursing homes was greater than 1,and the average total factor productivity change index was 0.907.Conclusion:The allocation efficiency of health resources in various medical institutions in Beijing needs to be improved.It is suggested that the government should strengthen macro-control and allocate health resources in combination with the market;accelerate the promotion of hierarchical diagnosis and treatment system,adjust the structure of medical resources,and improve the utilization rate of resources;make full use of psychiatric hospital health resources,avoid resource waste;improve technical ability and promote technological innovation.